论文部分内容阅读
本文总结25年间积累的垂体嗜酸细胞瘤129例放疗的临床体会。全组总控制率达83.7％,劳动能力恢复率为36.3％。从随诊结果看,其放疗适宜剂量应在4,000拉得左右,不得低于3,700拉得,此剂量比灰色细、胞瘤所需高500拉得,由于嗜酸细胞瘤放疗疗效的日益改进,应将放疗列为首要的和首选的方法,使更多的病人免去开颅手术之苦而挽救其视神经。文中还讨论了正常神经组织放射耐受量的问题。血清生长激素的测定有助于放疗不少具体问题的解决,应力争这一必备的条件。作者指出进一步提高疗效的难题在于对并发症的控制,以及骨关节增生的恢复。和厌色细胞瘤相比,是其不利之处。
This article summarizes the clinical experience of 129 cases of pituitary eosinophils accumulated in 25 years of radiotherapy. The total control rate of the whole group was 83.7%, and the recovery rate of labor ability was 36.3%. From the follow-up results, the appropriate dose of radiation therapy should be around 4,000 pull, not less than 3,700 pulled, this dose is higher than the gray fine, 500 tumor cells required to pull, due to the improvement of the efficacy of radiotherapy of eosinophils, Radiotherapy should be listed as the first and preferred method to save more patients from craniotomy and save their optic nerves. The issue of normal radiological tolerance is also discussed in the article. The determination of serum growth hormone helps radiotherapy to solve many specific problems and strives for this necessary condition. The authors pointed out that the challenge to further improve the curative effect lies in the control of complications and the recovery of bone and joint hyperplasia. Compared with chromocytoma, it is a disadvantage.